#1
EWTXEDGEWISE THERAPEUTICS INC
- Reported value
- $488.83M
- Portfolio weight
- 9.69%
Quarterly change: unchanged
Institutional 13F data
OrbiMed Advisors LLC 13F
See 108 stock and ETF positions for Q1 2026, including 49 new or increased positions and 54 reductions or exits, with the original SEC filing. Put and call options are excluded.
13F filing follow-along calculator
If KRW 1,000,000 followed the new and increased positions
Checking current prices and calculating the KRW 1,000,000 result.
OrbiMed Advisors LLC 13F top holdings
Q1 2026 · 108 stock & ETF positions · Filed 2026-05-15 · Data updated 2026-07-07
Ranked by quarter-end stock and ETF value reported on Form 13F. Put and call options are excluded. These are not current market values or execution prices.
- Reported stock & ETF value
- $5.02B
- Top 10 concentration
- 44.4%
#2
ELVNENLIVEN THERAPEUTICS INC
- Reported value
- $312.01M
- Portfolio weight
- 6.18%
Quarterly change: unchanged
#3
MDXHMDXHEALTH SA
- Reported value
- $285.9M
- Portfolio weight
- 5.67%
Quarterly change: new position
- Reported value
- $217.8M
- Portfolio weight
- 4.32%
Quarterly change: decreased -21.4%
#5
RCELAVITA MEDICAL INC
- Reported value
- $196.96M
- Portfolio weight
- 3.90%
Quarterly change: new position
#6
SVASINOVAC BIOTECH LTD
- Reported value
- $184.47M
- Portfolio weight
- 3.66%
Quarterly change: unchanged
#7
BSXBOSTON SCIENTIFIC CORP
- Reported value
- $149.48M
- Portfolio weight
- 2.96%
Quarterly change: decreased -1.5%
#8
SIONSIONNA THERAPEUTICS INC
- Reported value
- $141.55M
- Portfolio weight
- 2.81%
Quarterly change: decreased -0.9%
#9
AZNASTRAZENECA PLC
- Reported value
- $132.18M
- Portfolio weight
- 2.62%
Quarterly change: new position
#10
MYGNMYRIAD GENETICS INC
- Reported value
- $122.88M
- Portfolio weight
- 2.44%
Quarterly change: new position
#11
MBXMBX BIOSCIENCES INC
- Reported value
- $108.59M
- Portfolio weight
- 2.15%
Quarterly change: decreased -7.6%
#12
CRVSCORVUS PHARMACEUTICALS INC
- Reported value
- $104.82M
- Portfolio weight
- 2.08%
Quarterly change: unchanged
Largest new or increased positions
#1
MDXHMDXHEALTH SA
- Reported value
- $285.9M
- Portfolio weight
- 5.67%
Quarterly change: new position
#2
RCELAVITA MEDICAL INC
- Reported value
- $196.96M
- Portfolio weight
- 3.90%
Quarterly change: new position
#3
AZNASTRAZENECA PLC
- Reported value
- $132.18M
- Portfolio weight
- 2.62%
Quarterly change: new position
#4
MYGNMYRIAD GENETICS INC
- Reported value
- $122.88M
- Portfolio weight
- 2.44%
Quarterly change: new position
#5
MRKMERCK & CO INC
- Reported value
- $79.8M
- Portfolio weight
- 1.58%
Quarterly change: new position
#6
GPCRSTRUCTURE THERAPEUTICS INC
- Reported value
- $71.11M
- Portfolio weight
- 1.41%
Quarterly change: increased +27.0%
#7
XENEXENON PHARMACEUTICALS INC
- Reported value
- $61.64M
- Portfolio weight
- 1.22%
Quarterly change: increased +137.0%
#8
BMYBRISTOL-MYERS SQUIBB CO
- Reported value
- $56.1M
- Portfolio weight
- 1.11%
Quarterly change: increased +19.4%
Latest 13F filing snapshot
- Reporting period
- 2026-03-31
- Filed
- 2026-05-15
- Stock & ETF positions
- 108
- New or increased
- 49
- Reduced or exited
- 54
- Unchanged
- 25
Top reported buys
QURECMPSRCELRVMD
Counts cover unique stock and ETF positions and exclude put and call options, so they can differ from the SEC information-table row count. Form 13F reports quarter-end holdings and does not reveal every trade date or execution price.
View original SEC filings ↗